Acknowledgement
Supported by : Tehran University of Medical Sciences
References
- Albulescu R, Codrici E, Popescu ID, et al (2013). Cytokine patterns in brain tumour progression. Mediators Inflamm, 2013, 979748.
- Anton K, Glod J (2014). An Orchestrated Response To Tumor Signals By Macrophages and Mesenchymal Stem Cells Potentiates Interleukin-6 Secretion In Glioblastoma. Cell death in therapy, 1.
- Antoniades V, Sioga A, Dietrich EM, et al (2013). Is copper chelation an effective anti-angiogenic strategy for cancer treatment? Med Hypotheses, 81, 1159-63. https://doi.org/10.1016/j.mehy.2013.09.035
- Brat DJ, Bellail AC, Van Meir EG (2005). The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol, 7, 122-33. https://doi.org/10.1215/S1152851704001061
- Brem S, Grossman SA, Carson KA, et al (2005). Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma. Neuro Oncol, 7, 246-53. https://doi.org/10.1215/S1152851704000869
- Carmeliet P (2005). Angiogenesis in life, disease and medicine. Nature, 438, 932-6. https://doi.org/10.1038/nature04478
- Chang Q, Bournazou E, Sansone P, et al (2013). The IL-6/JAK/stat3 feed-forward loop drives tumorigenesis and metastasis. Neoplasia, 15, 848-IN45. https://doi.org/10.1593/neo.13706
- Chen WH, Chen Y, Cui GH (2005). Effects of TNF-alpha and curcumin on the expression of VEGF in Raji and U937 cells and on angiogenesis in ECV304 cells. Chin Med J (Engl), 118, 2052-7.
- Davis FG, Freels S, Grutsch J, et al (1998). Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg, 88, 1-10. https://doi.org/10.3171/jns.1998.88.1.0001
- Farah P, Blanda R, Kromer C, et al (2016). Conditional survival after diagnosis with malignant brain and central nervous system tumor in the United States, 1995-2012. J Neurooncol, 128, 419-29. https://doi.org/10.1007/s11060-016-2127-8
- Fukumura D, Jain RK (2007). Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res, 74, 72-84. https://doi.org/10.1016/j.mvr.2007.05.003
- Gopinathan G, Milagre C, Pearce OM, et al (2015). Interleukin-6 Stimulates Defective Angiogenesis. Cancer Res, 75, 3098-107. https://doi.org/10.1158/0008-5472.CAN-15-1227
- Hanahan D, Folkman J (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. cell, 86, 353-64. https://doi.org/10.1016/S0092-8674(00)80108-7
- Kaur B, Khwaja FW, Severson EA, et al (2005). Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol, 7, 134-53. https://doi.org/10.1215/S1152851704001115
- Kim NH, Jung HJ, Shibasaki F, et al (2010). NBBA, a synthetic small molecule, inhibits TNF-alpha-induced angiogenesis by suppressing the NF-kappaB signaling pathway. Biochem Biophys Res Commun, 391, 1500-5. https://doi.org/10.1016/j.bbrc.2009.12.101
- Koca T, Basaran H, Sezen D, et al (2014). Comparison of linear accelerator and helical tomotherapy plans for glioblastoma multiforme patients. Asian Pac J Cancer Prev, 15, 7811-6. https://doi.org/10.7314/APJCP.2014.15.18.7811
- Kumar A, Sunita P, Jha S, et al (2016). Daphnetin inhibits TNFalpha and VEGF-induced angiogenesis through inhibition of the IKKs/IkappaBalpha/NF-kappaB, Src/FAK/ERK1/2 and Akt Signaling Pathways. Clin Exp Pharmacol Physiol, 14, 1440-681.
- Kwon YW, Heo SC, Jeong GO, et al (2013). Tumor necrosis factor-alpha-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis. Biochim Biophys Acta, 1832, 2136-44. https://doi.org/10.1016/j.bbadis.2013.08.002
- Lai KC, Liu CJ, Lin TJ, et al (2016). Blocking TNF-alpha inhibits angiogenesis and growth of IFIT2-depleted metastatic oral squamous cell carcinoma cells. Cancer Lett, 370, 207-15. https://doi.org/10.1016/j.canlet.2015.10.016
- Liu Y, Yang G, Zhang J, et al (2015). Anti-TNF-alpha monoclonal antibody reverses psoriasis through dual inhibition of inflammation and angiogenesis. Int Immunopharmacol, 28, 731-43. https://doi.org/10.1016/j.intimp.2015.07.036
- Mihara M, Hashizume M, Yoshida H, et al (2012). IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond), 122, 143-59. https://doi.org/10.1042/CS20110340
- Milstein JM, Cohen ME, Sinks LF (1985). The influence and reliability of neurologic assessment and Karnofsky performance score on prognosis. Cancer, 56, 1834-6. https://doi.org/10.1002/1097-0142(19851001)56:7+<1834::AID-CNCR2820561323>3.0.CO;2-A
- Mor V, Laliberte L, Morris JN, et al (1984). The Karnofsky performance status scale: an examination of its reliability and validity in a research setting. Cancer, 53, 2002-7. https://doi.org/10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W
- Nasulewicz A, Mazur A, Opolski A (2004). Role of copper in tumour angiogenesis-clinical implications. J Trace Elem Med Biol, 18, 1-8. https://doi.org/10.1016/j.jtemb.2004.02.004
- Ni W, Luo L, Ping Z, et al (2014). Prognostic value of ALDH1A3 promoter methylation in gliob; astoma: a single center experience in Western China. Asian Pac J Cancer Prev, 16, 591-4.
- Pashaki AS, Hamed EA, Mohamadian K, et al (2014). Efficacy of high dose radiotherapy in post-operative treatment of glioblastoma multiform--a single institution report. Asian Pac J Cancer Prev, 15, 2793-6. https://doi.org/10.7314/APJCP.2014.15.6.2793
- Qin JJ, Wang JM, Du J, et al (2013). Radixin knockdown by RNA interference suppresses human glioblastoma cell growth in vitro and in vivo. Asian Pac J Cancer Prev, 15, 9805-12.
- Qin JJ, Liu ZX, Wang JM, et al (2015). Prognostic factors influencing clinical outcomes of malignant glioblastoma multiforme: clinical, immunophenotypic, and fluorescence in situ hybridization findings for 1p19q in 816 chinese cases. Asian Pac J Cancer Prev, 16, 971-7. https://doi.org/10.7314/APJCP.2015.16.3.971
- Raluca BA, Cimpean AM, Cioca A, et al (2014). Endothelial Cell Proliferation and Vascular Endothelial Growth Factor Expression in Primary Colorectal Cancer and Corresponding Liver Metastases. Asian Pac J Cancer Prev, 16, 4549-53.
- Redmond KJ, Mehta M (2015). Stereotactic Radiosurgery for Glioblastoma. Cureus, 7, 413.
- Reiss Y, Machein MR, Plate KH (2005). The role of angiopoietins during angiogenesis in gliomas. Brain Pathol, 15, 311-7.
- Riaz SK, Iqbal Y, Malik M (2014). Diagnostic and therapeutic implications of the vascular endothelial growth factor family in cancer. Asian Pac J Cancer Prev, 16, 1677-82.
- Schmidt NO, Westphal M, Hagel C, et al (1999). Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer, 84, 8-10.
- Shin MR, Kang SK, Kim YS, et al (2015). TNF-alpha and LPS activate angiogenesis via VEGF and SIRT1 signalling in human dental pulp cells. Int Endod J, 48, 705-16. https://doi.org/10.1111/iej.12396
- Urso E, Maffia M (2015). Behind the Link between Copper and Angiogenesis: established mechanisms and an overview on the role of vascular copper transport systems. J Vasc Res, 52, 172-96. https://doi.org/10.1159/000438485
- Wadhwa S, Mumper RJ (2013). D-penicillamine and other low molecular weight thiols: review of anticancer effects and related mechanisms. Cancer Lett, 337, 8-21. https://doi.org/10.1016/j.canlet.2013.05.027
- Wang L-F, Fokas E, Juricko J, et al (2008). Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients. BMC Cancer, 8, 1. https://doi.org/10.1186/1471-2407-8-1
- Weathers SP, de Groot J (2015). VEGF manipulation in glioblastoma. J Clin Oncol, 29, 719.
- Xu H, Zhu J, Gu L, et al (2015). VEGFR2 Expression in Head and Neck Squamous Cell Carcinoma Cancer Cells Mediates Proliferation and Invasion. Asian Pac J Cancer Prev, 17, 2217-21.
- Yang HL, Chang HC, Lin SW, et al (2014). Antrodia salmonea inhibits TNF-alpha-induced angiogenesis and atherogenesis in human endothelial cells through the down-regulation of NF-kappaB and up-regulation of Nrf2 signaling pathways. J Ethnopharmacol, 151, 394-406. https://doi.org/10.1016/j.jep.2013.10.052
- Yoshida D, Ikeda Y, Nakazawa S (1995). Suppression of tumor growth in experimental 9L gliosarcoma model by copper depletion. Neurol Med Chir, 35, 133-5. https://doi.org/10.2176/nmc.35.133
- Yu J, Cao X-F, Zheng Y, et al (2013). Anti-VEGF Therapy with Bevacizumab--limited cardiovascular toxicity. Asian Pac J Cancer Prev, 15, 10769-72.
- Zhang Y, Yu LK, Lu GJ, et al (2013). Prognostic values of VEGF and endostatin with malignant pleural effusions in patients with lung cancer. Asian Pac J Cancer Prev, 15, 8435-40.